Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies (Tables)

v3.25.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities

The following common stock equivalents were excluded in the computation of the net loss per share because their effect is anti-dilutive:

 

   

June 30, 2025

(Unaudited)

   

June 30, 2024

(Unaudited)

 
Series L convertible preferred stock 1     3,084,382        
Options to purchase common stock     124,600       126,265  
Warrants to purchase common stock     16,751,669       1,133,762  
Total anti-dilutive securities     19,960,651       1,260,027  

 

1 Converted into common stock using a conversion price of $2.043 per share, as of June 30, 2025